Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erik J. Verner"'
Autor:
Timothy D. Owens, Ken A. Brameld, Erik J. Verner, Tony Ton, Xiaoyan Li, Jiang Zhu, Mohammad R. Masjedizadeh, J. Michael Bradshaw, Ronald J. Hill, Danny Tam, Angelina Bisconte, Eun Ok Kim, Michelle Francesco, Yan Xing, Jin Shu, Dane Karr, Jacob LaStant, David Finkle, Natalie Loewenstein, Helena Haberstock-Debic, Michael J. Taylor, Philip Nunn, Claire L. Langrish, David M. Goldstein
Publikováno v:
Journal of medicinal chemistry. 65(7)
Bruton's tyrosine kinase (BTK), a Tec family tyrosine kinase, is critical in immune pathways as an essential intracellular signaling element, participating in both adaptive and immune responses. Currently approved BTK inhibitors are irreversible cova
Autor:
Erik J. Verner, Theodore Cohen
Publikováno v:
ChemInform. 23
Autor:
Erik J. Verner, Theodore Cohen
Publikováno v:
Journal of the American Chemical Society. 114:375-377
Publikováno v:
ChemInform. 21
Phosphonitrilic dichloride cyclic trimer has been found to be an effective activating agent for the synthesis of oligopeptides containing N-terminal isoxazole-4-carboxamide groups
Autor:
Theodore Cohen, Erik J. Verner
Publikováno v:
The Journal of Organic Chemistry. 57:1072-1073
The presence of a 4-tert-butyl group on 2-lithio-6-(trans-1-propenyl)tetrahydropyran dramatically changes the rearrangement behavior, inhibiting the formation of [2,3]-Wittig rearrangement product and leading to a 1,4-transannular H-transfer to the l
Autor:
Tyrone V. Arnold, Michael D. Mosher, Erik J. Verner, Nicholas R. Natale, Nicholas Vietri, Daniel Hamlin, Bradford J. Oliver, Robert B. Palmer
Publikováno v:
Journal of Chemical Education. 73:1036
The search for more efficient anticancer and antiviral agents has included the preparation and testing of a wide variety of molecules that bind DNA. Of these, particular attention has been devoted to the synthesis of analogues of DNA minor-groove bin
Publikováno v:
HETEROCYCLES. 31:327
Phosphonitrilic dichloride cyclic trimer has been found to be an effective activating agent for the synthesis of oligopeptides containing N-terminal isoxazole-4-carboxamide groups